​

​

Six Months Ended June 30, 

​

  ​ ​ ​

2026

  ​ ​ ​

2025

​

(in US$’000)

Clinical trial related costs

​

30,722

​

38,019

Personnel compensation and related costs (note)

​

41,083

​

30,063

Other research and development expenses

​

6,978

​

3,908

​

​

78,783

​

71,990